ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Merus NV

Merus NV (2GH)

43.40
0.00
( 0.00% )
Updated: 02:31:17
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
43.40
Bid
42.80
Offer
43.20
Volume
495
43.40 Day's Range 43.80
21.40 52 Week Range 58.50
Previous Close
43.40
Open
43.80
Last Trade
90
@
43.4
Last Trade Time
01:58:53
Average Volume (3m)
114
Financial Volume
-
VWAP
-

2GH Latest News

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit Petosemtamab bekannt

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit...

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia – Les données...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

Merus annonce sa participation aux prochaines journées Investisseurs

Merus annonce sa participation aux prochaines journées Investisseurs UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 07 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une...

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein Unternehmen aus...

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 05 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.20.46296296296343.247437546.60089286DE
4-6.6-13.25051.540.49946.46118598DE
12-2-4.4052863436145.451.540.411447.6509915DE
26-3.2-6.866952789746.657.540.415348.80237835DE
5222.000001102.80374779521.39999958.521.39999917044.3573342DE
15619.682.352941176523.858.51916541.98058262DE
26019.682.352941176523.858.51916541.98058262DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
17DArcadia Biosciences Inc
8.35 €
(223.64%)
4.21k
1KPAProtara Therapeutics Inc
6.65 €
(97.92%)
13.55k
L7C2Windfall Geotek Inc
0.006 €
(50.00%)
18k
PA8Paion AG
0.028 €
(38.61%)
38.23k
TE9Teco 2030 ASA
0.034 €
(38.21%)
718.92k
YM4Raiden Resources Limited
0.005 €
(-47.37%)
1.02M
CNWCodon AG
0.0065 €
(-40.91%)
1.5k
KASHIntellabridge Technology Corp
0.0155 €
(-40.38%)
1.2k
DW8Tantalex Lithium Resources Corp
0.0115 €
(-39.47%)
2k
37NImagine Lithium Inc
0.006 €
(-36.84%)
5k
D7GNel ASA
0.2613 €
(-2.32%)
4.11M
R9BDeFi Technologies Inc
3.395 €
(4.14%)
2.27M
AXIAtos SE
0.2374 €
(-24.63%)
2.12M
TUI1Tui AG
8.234 €
(4.20%)
1.57M
LHADeutsche Lufthansa AG
6.59 €
(4.97%)
1.05M

Discussion

View Full Feed
TRUSTUNITS1000000 TRUSTUNITS1000000 1 minute ago
Toll free number
INDR
vein vein 2 minutes ago
I have a lot of regrets here for sure . Only myself to blame for not selling more ! My only hopes are we actually have something more than a science experiment! 
LWLG
TRUSTUNITS1000000 TRUSTUNITS1000000 2 minutes ago
Shareholders post
INDR
elks elks 2 minutes ago
Looking good here !!!!!!!
HMBL
Eli-316 Eli-316 2 minutes ago
8s are falling, 9s real thin 
CGAC
TRUSTUNITS1000000 TRUSTUNITS1000000 2 minutes ago
Market capitalization $132
INDR
getmoreshares getmoreshares 2 minutes ago
he has been here before-- couple weeks ago-- don't believe he held-- IMO he is trading it again
CGAC
firebag1 firebag1 2 minutes ago
oh the word has been out.....just waiting for the catalyst to make this go Kabooooooooooom rak lol
CGAC
jdcpa1 jdcpa1 2 minutes ago
What is the investment price being offered in wefunder for azrh common? Does anyone know? Thanks!
AZRH
Jofffff Jofffff 2 minutes ago
I have 70000000 shared at this point .... and I'm watching for others🤠
ASII
zandant zandant 2 minutes ago
Even Ehrlich, the biggest lying hypster around, has abandoned this sunken ship. Once the appeal is lost, the bones of IPIX will turn to dust...and the $4 million wasted on the Laser Boys should be on Ehrlich's failed company's virtual grave.
IPIX
Rainer Rainer 2 minutes ago
HMBL wow, what a move
HMBL
Mr. Zen Mr. Zen 2 minutes ago
go4: thanks for your perspective, I have (for the past 24 years) played penny stocks as a hobby and I have done quite well so I have a different perspective::: I own this because of a reverse merger it has gone through, it was a looser before the reverse merger and that is why the CEO and controllin
AESO
TRUSTUNITS1000000 TRUSTUNITS1000000 2 minutes ago
INDR $132 market capitalization
INDR
ExtremelyBullishZig ExtremelyBullishZig 2 minutes ago
There is no manipulation down, only up. How are you so blind. It was pumped and pumped with nothing to pump. All the market did is figured the last date of listed presentations and they got out after the last one. That isn't manipulation on the down side...just pumpers causing problems and blaming t
AVXL
mike_dotcom mike_dotcom 2 minutes ago
"waiting to reload" so you admit you're smart enough to sell this garbage every time Missling opens his mouth?
AVXL
Rattlershehe Rattlershehe 3 minutes ago
A movie showing 30,000 shares at .042 Of course that's after somebody bought 70,000 shares at .042 I think what slowing it down is while it was fantastic news it wasn't sexy. There was no numbers in it to represent the future growth financially of the company.
KRTL
LowFloatLopes LowFloatLopes 3 minutes ago
Someone just made an exit ..I hope that was the last of our unhinged lunatic 
AZRH
learningcurve2020 learningcurve2020 3 minutes ago
Attaboy, Flopper. 
NWBO
JJZander JJZander 3 minutes ago
HMBL .0026
HMBL
Vector2112 Vector2112 3 minutes ago
This stock needs to get above 1.00 and stay for at least 30 days.
RR
Chartmaster Chartmaster 3 minutes ago
27's up!!! Still thinking nonsense are U??? Lol!
HMBL
Gman3343 Gman3343 3 minutes ago
We will get .001 at pink current, and hopefully if they have a big sweet merger we should see a penny hopefully more.
EEGI
IhidfromtheX IhidfromtheX 3 minutes ago
If I can make it until tomorrow....I will have reached the average lifespan after Whipple Surgery...I wish I knew how the long term Anavex patients are comparing to the average lifespan of Alzheimer's patients!
AVXL